In a reversal, Biogen will ask the FDA to approve its Alzheimer’s drug
Update: 2025-09-27
Description
In a stunning reversal, Biogen says it will ask the US Food and Drug Administration to approve its Alzheimer’s disease treatment aducanumab.In March, the biotech firm pulled the plug on Phase III studies of the antibody, which breaks up amyloid-? plaques in the brain, after an independent review b....
This item belongs to: audio/rivet360-audio-collection.
This item has files of the following types: Archive BitTorrent, Columbia Peaks, Metadata, PNG, Spectrogram, VBR MP3
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
